Global Veterinary Antiseptics Market - 2024-2031

Overview

The global veterinary antiseptics market reached US$ 43.05 billion in 2023 and is expected to reach US$ 83.31 billion by 2031 growing with a CAGR of 8.6% during the forecast period 2024-2031.

Veterinary antiseptics are topical preparations used to prevent or reduce the growth of microorganisms on the skin and mucous membranes of animals. They are used to disinfect and clean wounds, as well as to prevent infection and promote healing.

Veterinary antiseptics are solutions, creams, or ointments that contain antimicrobial agents that are applied to wounds, cuts, and other areas prone to infection in livestock, companion animals, and other animal populations.

The market is driven by factors such as the rise in infectious diseases among animals & advancement in veterinary medicine and increasing pet ownership.

Market Dynamics: Drivers

Rise in infectious diseases among animals and advancement in veterinary medicine

The demand for the global veterinary antiseptics market is driven by multiple factors. One of the primary factors is the rise in infectious diseases among animals and advancements in veterinary medicine are significant drivers of the veterinary antiseptics market.

The rising incidence of infectious diseases in livestock, companion animals, and other animals is a major driver for the veterinary antiseptics market. In veterinary medicine, antibacterials and anti-infectives, such as antifungals, antivirals, and others, are commonly used to treat infectious disorders caused by bacteria and other microorganisms.

According to the World Organisation for Animal Health (OIE), the number of reported outbreaks of animal diseases has increased by 20% over the past decade. This surge in disease prevalence is attributed to various factors, including climate change, increased trade and travel, and changes in animal husbandry practices. According to WHO data in October 2023, some 60% of emerging infectious diseases that are reported globally come from animals.

Moreover, key player strategies such as mergers & acquisitions and innovative launches in the veterinary antiseptics are expected to drive market growth. For instance, in March 2024, Virbac announces that it has signed a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of approximately €280 million.

Also, in March 2022, Virbac reformulated Vet Aquadent, the solution used in daily drinking water to reduce plaque build-up in cats and dogs, with its FR3SH technology ingredients. The addition of antiseptics to treats or water additives is an attractive method for treating periodontal disease.

Restraints

Factors such as stringent regulations, the high cost of the development process of veterinary antiseptics, lack of awareness among individuals, and emerging drug resistance, are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global veterinary antiseptics market is segmented based on product type, route of administration, application, distribution channels, and region.

The livestock animal segment accounted for approximately 59.4% of the global veterinary antiseptics market share

The livestock animal segment is expected to hold the largest market share over the forecast period. Fish, poultry, swine, cattle, sheep, and goats are among the subcategories of the livestock segment. Growing everyday necessities, environmental sustainability, and rising meat consumption are all expected to contribute to this segment's significant expansion. For instance, the US Department of Agriculture (USDA) reported in May 2024 that from January to April 2024, the country produced approximately 8,863 million pounds of beef.

Moreover, the rising prevalence of infectious diseases in livestock animals helps to drive this segment's growth in the market. According to the Indian Council of Agriculture Research data published in 2023, during an outbreak of Lumpy skin diseases, 29.45 lakh cattle were infected and caused over 1.55 lakh deaths in over 15 states of India. Because India is a prominent dairy producer worldwide, this drives the demand for veterinary anti-infective drugs.

In addition, the increasing number of livestock, and the growing adoption of pets. A significant number of cattle and growing healthcare spending on veterinary care and animal health are additional significant factors anticipated to drive market expansion. For instance, in April 2024 data by USDA, nearly 30 percent of all cattle worldwide are found in China and India. The expanding population of livestock has boosted the demand for the production of meat and dairy products, which is predicted to fuel the demand for veterinary antibiotics for livestock animals.

Also, in March 2021, Zoetis announced the purchase of a 21-acre manufacturing site in Melbourne, to significantly expand its current operations at the site and increase future capabilities to develop and manufacture vaccines for sheep, cattle, dogs, cats, and horses.

Geographical Analysis

North America accounted for approximately 41.4% of the global veterinary antiseptics market share

North America will hold the largest market share over the forecast period owing to the growing pet ownership and companion animal population in the region. Increasing disposable incomes, urbanization, and changing lifestyles have led to a surge in pet adoptions, especially of dogs and cats, in countries such as the United States and Canada.

Veterinarians are increasingly adopting advanced antiseptic products and protocols to prevent and manage infections in both companion animals and livestock. This trend is supported by growing awareness among pet owners and farmers about the importance of infection control.

Moreover, the major number of key players' presence, well-advanced healthcare infrastructure, technological advancements, and product launches and approvals would propel this market growth in this region. For instance, in July 2023, Bimeda Inc. announced that SpectoGard (spectinomycin sulfate) Sterile Solution which received FDA approval in September of 2022-is available for veterinarians and cattle producers in the United States. SpectoGard Sterile Solution is the first bioequivalent, generic spectinomycin sulfate injectable solution that is approved for use in cattle for the treatment of bovine respiratory disease (pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.

Similarly, in September 2023, the US Food and Drug Administration (FDA) released an updated 5-year action plan for supporting antimicrobial stewardship in veterinary settings. The plan from the FDA's Center for Veterinary Medicine (CVM) contains a series of actions organized under three goals.

Market Segmentation

By Product Type

• Iodine & Iodophors
• Chlorhexidine
• Alcohol
• Hydrogen Peroxide
• Others

By Route of Administration

• Oral
• Injectable
• Topical

By Application

• Livestock Animal
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
  • Others
• Companion Animal
  • Dogs
  • Cats
  • Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies & Pet Stores
• Online Pharmacies

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the veterinary antiseptics market include Zoetis Services LLC, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Dechra Pharmaceuticals PLC, Elanco, Ceva, Virbac, Biogenesis Bago, Vetoquinol and LABORATORIOS CALIER, S.A. among others.

Key Developments

• In April 2024, Johnson's Veterinary Products added to its extensive health and wellbeing range with the introduction of two new balms aimed at dogs, cats, and small animals. The new products, an Antiseptic Balm and a Soothing Skin Balm for dogs, cats, and small animals, expand on the success of Johnson's existing Paw & Nose Balm for dogs, which launched last year, creating a trio of all-natural and vegan-friendly balms, that deliver a wide range of important healthcare benefits from soothing irritated skin to treating minor cuts and abrasions.
• In January 2024, Merck Animal Health announced the European Commission (EC) has approved BRAVECTO (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs.
• In February 2023, Dechra launched Tri-Solfen, a new topical anesthetic and antiseptic gel. The gel is easy to administer and fast-acting (effective in just 30 seconds), providing a practical tool to improve animal welfare via cutaneous and epilesional use.

Why Purchase the Report?

• To visualize the global veterinary antiseptics market segmentation based on product type, route of administration, application, distribution channels, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the antinauseant drugs market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global veterinary antiseptics market report would provide approximately 72 tables, 70 figures, and 184 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies